133 related articles for article (PubMed ID: 31020343)
1. Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas.
Hasse A; Dapash M; Jeong Y; Ansari SA; Carroll TJ; Lesniak M; Ginat DT
Neuroradiology; 2019 Aug; 61(8):861-867. PubMed ID: 31020343
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression.
Sipos TC; Kövecsi A; Kocsis L; Nagy-Bota M; Pap Z
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928515
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.
Ozturk K; Soylu E; Tolunay S; Narter S; Hakyemez B
World Neurosurg; 2019 Aug; 128():e195-e208. PubMed ID: 31003026
[TBL] [Abstract][Full Text] [Related]
4. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
5. Texture analysis parameters derived from T1-and T2-weighted magnetic resonance images can reflect Ki67 index in soft tissue sarcoma.
Meyer HJ; Renatus K; Höhn AK; Hamerla G; Schopow N; Fakler J; Josten C; Surov A
Surg Oncol; 2019 Sep; 30():92-97. PubMed ID: 31500794
[TBL] [Abstract][Full Text] [Related]
6. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
[TBL] [Abstract][Full Text] [Related]
7. Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
Pérez-Beteta J; Molina-García D; Ortiz-Alhambra JA; Fernández-Romero A; Luque B; Arregui E; Calvo M; Borrás JM; Meléndez B; Rodríguez de Lope Á; Moreno de la Presa R; Iglesias Bayo L; Barcia JA; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Revert A; Arana E; Pérez-García VM
Radiology; 2018 Jul; 288(1):218-225. PubMed ID: 29924716
[TBL] [Abstract][Full Text] [Related]
8. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
9. Radiomic prediction models for the level of Ki-67 and p53 in glioma.
Sun X; Pang P; Lou L; Feng Q; Ding Z; Zhou J
J Int Med Res; 2020 May; 48(5):300060520914466. PubMed ID: 32431205
[TBL] [Abstract][Full Text] [Related]
10. T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.
Arevalo-Perez J; Thomas AA; Kaley T; Lyo J; Peck KK; Holodny AI; Mellinghoff IK; Shi W; Zhang Z; Young RJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2256-61. PubMed ID: 26338913
[TBL] [Abstract][Full Text] [Related]
11. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
[TBL] [Abstract][Full Text] [Related]
14. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Chaddad A; Desrosiers C; Hassan L; Tanougast C
Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
16. Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups.
Pérez-Beteta J; Molina-García D; Villena M; Rodríguez MJ; Velásquez C; Martino J; Meléndez-Asensio B; Rodríguez de Lope Á; Morcillo R; Sepúlveda JM; Hernández-Laín A; Ramos A; Barcia JA; Lara PC; Albillo D; Revert A; Arana E; Pérez-García VM
AJNR Am J Neuroradiol; 2019 Apr; 40(4):634-640. PubMed ID: 30923085
[TBL] [Abstract][Full Text] [Related]
17. The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.
Rotkopf LT; Wiestler B; Preibisch C; Liesche-Starnecker F; Pyka T; Nörenberg D; Bette S; Gempt J; Thierfelder KM; Zimmer C; Huber T
PLoS One; 2020; 15(1):e0228030. PubMed ID: 31971966
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing brain abscess from necrotic glioblastoma using MRI-based intranodular radiomic features and peritumoral edema/tumor volume ratio.
Xiao D; Wang J; Wang X; Fu P; Zhao H; Yan P; Jiang X
J Integr Neurosci; 2021 Sep; 20(3):623-634. PubMed ID: 34645095
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
[TBL] [Abstract][Full Text] [Related]
20. Histogram Analysis Parameters Derived from Conventional T1- and T2-Weighted Images Can Predict Different Histopathological Features Including Expression of Ki67, EGFR, VEGF, HIF-1α, and p53 and Cell Count in Head and Neck Squamous Cell Carcinoma.
Meyer HJ; Leifels L; Hamerla G; Höhn AK; Surov A
Mol Imaging Biol; 2019 Aug; 21(4):740-746. PubMed ID: 30284155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
